Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors

Overview of attention for article published in Clinical Epidemiology, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 1 news story.

Seeking Alpha has been abuzz about Ariad Pharmaceuticals (NASDAQ: ARIA ) as of late.